Deltec Asset Management’s Turnstone Biologics TSBX Stock Holding History

Deltec Asset Management’s Portfolio TSBX Stock Details TSBX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-106,057	Closed	-$38.1K	–	222
2025 Q2	$38.1K	Buy	+106,057	New	+$37.2K	0.01%	185

Deltec Asset Management's TSBX Position: Q3 2025 in Review

Deltec Asset Management sold out of Turnstone Biologics (TSBX) in Q3 2025, closing a stake of 106,057 shares — an estimated $38.1K sold.

Deltec Asset Management first reported a position in TSBX in Q2 2025 and held it in 1 quarter. The position peaked at $38.1K in Q2 2025. 1 fund tracked by Wall St. Rank holds TSBX as of Q3 2025.

Deltec Asset Management reported no remaining Turnstone Biologics position as of Q3 2025 after selling out during the quarter.
Deltec Asset Management sold 106,057 Turnstone Biologics shares in Q3 2025, an estimated $38.1K.
Deltec Asset Management first reported a position in Turnstone Biologics in Q2 2025 and held it in 1 quarter.
Deltec Asset Management's Turnstone Biologics position peaked at $38.1K in Q2 2025.
1 fund tracked by Wall St. Rank held Turnstone Biologics as of Q3 2025.

Based on Deltec Asset Management's 13F filing for Q3 2025, filed 24 Oct 2025.